Greater Philadelphia
💼 Executive Business Development Leader | Biologics CMC I am a seasoned business development and strategic leader in the biopharmaceutical industry, specializing in biologics, mAbs, vaccines, recombinant proteins, and peptides. With extensive experience spanning CDMOs, bioanalytical services, and antibody platforms, I partner with biotech and pharmaceutical sponsors to translate complex CMC programs into scalable, regulatory-ready solutions. 🚀 I bring a rare combination of commercial leadership and deep technical expertise, enabling me to engage credibly with scientific, operational, and executive stakeholders while driving long-term client partnerships and revenue growth. Core strengths include: 📈 Business Development & Revenue Growth – Identifying, cultivating, and closing strategic opportunities across early-stage to clinical-stage programs. 🤝 Client Relationship Management – Building trusted, long-term partnerships with biotech and pharma sponsors. 🧬 Biologics & CMC Expertise – Deep understanding of drug substance, analytical development, GMP release, stability testing, and regulatory considerations. 📝 Contract Negotiation & Deal Structuring – Aligning technical scope, timelines, and commercial objectives for complex agreements. ⚡ Cross-Functional Leadership – Leading teams across MSAT, QC, QA, Manufacturing, and Analytical Development. 💡 Strategic Planning & Advisory – Advising on CDMO selection, vendor management, pipeline optimization, and IP/technical considerations. 🌍 Over my career, I have led business development initiatives and consultative partnerships across North America and Europe, supporting CDMOs and biotech clients with end-to-end biologics programs from discovery through post-launch. If your organization is seeking a results-driven, technically fluent executive to grow biologics CDMO partnerships, let’s connect!
📊 Provide advisory services for early-stage and clinical-stage biopharmaceutical clients seeking CDMO partnerships, outsourcing strategies, and CMC program planning. 🤝 Assist clients in vendor evaluation, contract negotiation, and technical scoping of biologics manufacturing and analytical services. 🔬 Guide clients on biologics development programs, including mAbs, recombinant proteins, vaccines, and peptide therapeutics. 💡 Enable informed strategic decisions by integrating commercial, technical, and regulatory perspectives. 📈 Support growth initiatives and business development strategies to expand client pipelines and CDMO relationships.
🚀 Led biologics-focused business development strategy to expand footprint across the Northeast, targeting non-clinical through early-stage clinical programs. 💼 Drove new client acquisition for monoclonal antibody and recombinant protein manufacturing services. 🤝 Built executive-level relationships with emerging and established biotech sponsors, translating early CMC and manufacturing needs into scalable development pathways. 🔬 Collaborated cross-functionally with technical, analytical, MSAT, and manufacturing teams to align client requirements.
📈 Cultivated new business opportunities with non-clinical and early-stage clinical clients. 🤝 Led CDMO selection, vendor management, strategic consulting, and IP litigation support. 🧬 Translated complex technical and regulatory challenges into actionable solutions. 📝 Negotiated contracts and scoped project deliverables.
📈 Led business development for biologics CMC analytical services, driving new client acquisition for GMP release and stability testing across pharmaceutical and biotechnology organizations. 🌍 Expanded Catalent’s market presence by positioning analytical development and testing capabilities as critical enablers of regulatory readiness and clinical progression. 🤝 Partnered with client scientific and quality teams to scope analytical strategies aligned with CMC, regulatory, and program timelines. 📝 Negotiated service agreements and statements of work, balancing technical scope, timelines, and commercial considerations. 🔬 Collaborated cross-functionally with QC, QA, analytical development, and operations teams to deliver compliant, client-focused testing solutions.
📊 Led business development initiatives for biologics CMC analytical services, driving new and expanded business for GMP release and stability testing across clinical and commercial programs. 🤝 Built and expanded strategic relationships with large pharmaceutical and emerging biotechnology clients across the Mid-Atlantic region. 🔬 Positioned Covance’s end-to-end biologics analytical capabilities as critical enablers of regulatory compliance and lifecycle management from discovery through post-launch. 🧪 Advised clients on analytical strategies addressing safety, identity, strength, quality, and purity requirements throughout the product lifecycle. 📝 Negotiated complex service agreements and collaborated cross-functionally with analytical, project management, QA, and operations teams to deliver high-quality, compliant data.